LifeStance Health Group, Inc.
LFSTHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeLifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company carries a $4.86B market cap, placing it firmly in the mid-cap category. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Market Cap
$4.86B
Beta
1.22
P/E (TTM)
97.92
P/E (Fwd)
23.98
EPS (TTM)
$0.13
EPS (Fwd)
$0.53
ROE
3.4%
ROA
2.3%
Cash
$225.9M
Total Debt
$474.2M
Free CF
$172.4M
52W Change
132.1%
Annual Financials
Cash vs Debt
Where LFST stands vs its 150-day and 200-day moving averages
As of the August 31, 2026 close, LFST finished 44.99% above its 150-day moving average ($8.49) and 52.35% above its 200-day moving average ($8.08). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is LFST overbought or oversold?
At the August 31, 2026 close, LFST's RSI(14) was 56.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
LifeStance Health Group, Inc. carries $474.2M in total debt against $225.9M in cash reserves — debt is roughly 2.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $172.4M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 3.4% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.3% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $859.5M (2022) to $1.42B (2025), reflecting a 66% increase over the period.
The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. No single metric tells the full story. Reviewing LFST's risk profile alongside its fundamentals and technical indicators provides a more complete picture.